WELCOME 

Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London) 

OPENING REMARKS 

Tom Thesing, Managing Partner, Sidley (London)

Junaid Bajwa, Senior Partner, Head of UK + Science Partner for Pioneering Intelligence, Flagship Pioneering 

Simone Fishburn, Vice President and Editor-in-Chief, BioCentury

PHARMA BUSINESS DEVELOPMENT – SENIOR BD AND BIOTECH FIGURES DEBATE THE M&A, LICENSING, AND COLLABORATION CLIMATE. WHICH THERAPEUTIC AREAS AND GEOGRAPHIES ARE GARNERING THE MOST ATTENTION?

MODERATOR: Asher Rubin, Partner, Technology and Life Sciences Transactions, Sidley (Baltimore)

SPEAKERS:

Caroline Austin, Vice President, Head of Transactions, Business Development, AstraZeneca

Susan Hill, CEO, Mestag Therapeutics

Guillaume Vignon, Global Head BD&L Transactions, Novartis

“A LIFE IN PHARMA AND PIVOTING TO INNOVATION”

MODERATOR: Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London) 

SPEAKER: 

Richard Francis, President and CEO, Teva

PRIVATE EQUITY – WHAT IS THE OUTLOOK FOR PE INVESTMENT ACTIVITY ACROSS HEALTHCARE AND LIFE SCIENCES? WHICH DOMAINS WILL BE THE “WINNERS”?

MODERATOR: Annalisa Jenkins, Bio Pharma Thought Leader and Non-Executive Director, Compass Pathways

SPEAKERS:

Tony Drabble, Senior Principal, IQVIA

Andrea Pelliccia, Principal, LetterOne Health

Sharon Spangenberg, Senior Principal, Onex Partners

Dimitrios Tzivelis, Healthcare Investor, Permira

ARTIFICIAL INTELLIGENCE – TO WHAT EXTENT, AND WHERE, DOES AI REPRESENT AN INVESTMENT OPPORTUNITY ACROSS HEALTHCARE AND LIFE SCIENCES?

MODERATOR: Francesca Blythe, Partner, Privacy and Cybersecurity, Sidley (London)

SPEAKERS:

Dr. Hutan Ashrafian MD, PhD, MBA, Chief Scientific Officer, Preemptive Medicine and Health Security, Flagship Pioneering 

Keri Hildick PhD, Chief Strategy Officer, Perspectum

Edward Kliphuis, Partner, Sofinnova Partners

Dr. Umang Patel, Chief Clinical Information Officer, Microsoft 

A VIEW FROM THE BANKS – OPINIONS, INSIGHTS, AND PREDICTIONS ON THE MARKET FROM THE LEADING GLOBAL HEALTHCARE DEALMAKERS 

MODERATOR: Ian Johnston, Acting Global Pharmaceutical Correspondent, Financial Times

SPEAKERS:

Alberto Bertani, Managing Director, Global Healthcare Team, Morgan Stanley

Stefano Beschi, Partner, Rothschild & Co.

James Mitford, Managing Director, J.P. Morgan 

Dr. Zahid Moneer, Senior Managing Director, BNP Paribas

VENTURE/GROWTH CAPITAL – HOW ARE GLOBAL FUNDS INVESTING IN A MORE MUTED MARKET? HOW DO INVESTEES STAND OUT? VIEWS FROM LEADING GLOBAL LIFE SCIENCES INVESTORS

MODERATOR: Frank Rahmani, Partner, Emerging Companies and Venture Capital, Sidley (Palo Alto)

SPEAKERS:

Maina Bhaman, Partner, Sofinnova Partners

Roel Bulthuis, Managing Partner, Syncona Limited

Tim Funnell, Partner, DPhil, BS, Monograph Capital Partners

Dr. Ruth McKernan CBE, PhD, Venture Partner, SV Health Investors

CLOSING REMARKS

Fred Cohen, Partner and Chairman, MD, DPhil, Monograph Capital Partners